Skip to content

LifeLines: a population-based study to study disease overriding risk factors for the development of multifactorial diseases during lifetime.

LifeLines: a population-based study to study disease overriding risk factors for the development of multifactorial diseases during lifetime. - LifeLines

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31406
Enrollment
130000
Registered
2007-10-15
Start date
2007-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases with more than one cause Multifactorial diseases

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients registered in a general practice in the Northern provinces (Groningen Friesland, Drenthe), The Netherlands, between 25 and 50 years of age, their partners, and parents (in law).

Exclusion criteria

Exclusion criteria: - Severe psychiatric or physical illness, which makes participation in a broad study unfavourable, e.g. a terminal illness. - Not being able to understand the Dutch language. - Not being able to visit the general practitioner. - Not being able to fill in the questionnaires. As such at the discretion of the general practitioner.;Parents (in law) will not be excluded in case of the above mentioned criteria when a representative is willing to assist these participants in the performance of the study.;Pregnant women will be rescheduled until 6 months after pregnancy or 3 months after breast feeding.

Design outcomes

Primary

MeasureTime frame
The development of a disease related to aging, metabolic, endocrine, cardiovascular, renal or pulmonary disease, a musculoskeletal disorder, or psychopathology.

Secondary

MeasureTime frame
The incidence and prevalence of multifactorial diseases and their risk factors in individuals and their families will be determined. The burden of disease for the society in terms of care needed, consumed care and costs of care will be ascertained.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)